A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden

Sten FredriksonKarolinska Institutet, Karolinska University Hospital StockholmSweden

Euan McLeodIMS Health LondonUK

Nathaniel HenryIMS Health LondonUKCorrespondence[email protected]

Ashley PitcherIMS Health LondonUK

Julia LowinIMS Health LondonUK

Matthieu CucheMerck Serono S.A. GenevaSwitzerland

Liberty FajutraoMerck AB SolnaSweden

Rodolphe PerardMerck Serono Ltd MiddlesexUK

David BatesNewcastle University Newcastle upon TyneUK

Andrew ChanRuhr-University Bochum, St. Josef-Hospital BochumGermany

show all

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (4)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden

Articles from other publishers (4)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden

Citations (4)

Articles from other publishers (4)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date